Suppr超能文献

肥胖相关性肾病、高血压与慢性肾脏病:弗雷明汉心脏研究。

Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

机构信息

Framingham Heart Study, Framingham, MA, USA.

出版信息

Hypertension. 2011 Nov;58(5):784-90. doi: 10.1161/HYPERTENSIONAHA.111.175315. Epub 2011 Sep 19.

Abstract

Ectopic fat depots may mediate local and systemic disease. Animal models of diet-induced obesity demonstrate increased fat accumulation in the renal sinus. The association of renal sinus fat with hypertension, chronic kidney disease, and other metabolic disorders has not been studied in a large, community-based sample. Participants from the Framingham Heart Study (n=2923; mean age: 54 years; 51% women) underwent quantification of renal sinus fat area using computed tomography. High renal sinus fat ("fatty kidney") was defined using sex-specific 90th percentiles in a healthy referent subsample. Multivariable linear and logistic regression was used to model metabolic risk factors as a function of fatty kidney and log-transformed renal sinus fat. Multivariable models were adjusted for age, sex, and outcome-specific covariates and then additionally adjusted for body mass index or abdominal visceral adipose tissue. The prevalence of fatty kidney was 30.1% (n=879). Individuals with fatty kidney had a higher odds ratio (OR) of hypertension (OR: 2.12; P<0.0001), which persisted after adjustment for body mass index (OR: 1.49; P<0.0001) or visceral adipose tissue (OR: 1.24; P=0.049). Fatty kidney was also associated with an increased OR for chronic kidney disease (OR: 2.30; P=0.005), even after additionally adjusting for body mass index (OR: 1.86; P=0.04) or visceral adipose tissue (OR: 1.86; P=0.05). We observed no association between fatty kidney and diabetes mellitus after adjusting for visceral adipose tissue. In conclusion, fatty kidney is a common condition that is associated with an increased risk of hypertension and chronic kidney disease. Renal sinus fat may play a role in blood pressure regulation and chronic kidney disease.

摘要

异位脂肪沉积可能介导局部和全身疾病。饮食诱导肥胖的动物模型显示肾窦中脂肪堆积增加。肾窦脂肪与高血压、慢性肾脏病和其他代谢紊乱的相关性尚未在大型社区样本中进行研究。弗雷明汉心脏研究(Framingham Heart Study)的参与者(n=2923;平均年龄:54 岁;51%为女性)接受了使用计算机断层扫描对肾窦脂肪面积的定量评估。在健康参照亚组中,使用性别特异性第 90 百分位数定义高肾窦脂肪(“脂肪肾”)。多变量线性和逻辑回归用于模拟代谢危险因素作为脂肪肾和对数转换肾窦脂肪的函数。多变量模型调整了年龄、性别和特定结局的协变量,然后进一步调整了体重指数或腹部内脏脂肪组织。脂肪肾的患病率为 30.1%(n=879)。有脂肪肾的个体发生高血压的比值比(OR)更高(OR:2.12;P<0.0001),即使在调整了体重指数(OR:1.49;P<0.0001)或内脏脂肪组织(OR:1.24;P=0.049)后也是如此。脂肪肾与慢性肾脏病的 OR 增加也相关(OR:2.30;P=0.005),即使在进一步调整体重指数(OR:1.86;P=0.04)或内脏脂肪组织(OR:1.86;P=0.05)后也是如此。在调整内脏脂肪组织后,我们观察到脂肪肾与糖尿病之间没有关联。总之,脂肪肾是一种常见的疾病,与高血压和慢性肾脏病的风险增加有关。肾窦脂肪可能在血压调节和慢性肾脏病中发挥作用。

相似文献

引用本文的文献

9
Perirenal Adipose Tissue: Clinical Implication and Therapeutic Interventions.肾周脂肪组织:临床意义与治疗干预
Indian J Nephrol. 2024 Nov-Dec;34(6):573-582. doi: 10.25259/ijn_532_23. Epub 2024 Aug 22.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验